Form 4: Pediatrix Medical Group Executive Reports Stock Transaction

Curtis Pickert, EVP and Chief Operating Officer of Pediatrix Medical Group, reports a transaction involving common stock on March 1, 2024.

Summary

• On March 1, 2024, Curtis Pickert, the EVP and Chief Operating Officer of Pediatrix Medical Group, engaged in a transaction involving the company's common stock.
• 9,160 shares were disposed of to cover tax obligations upon vesting of restricted shares at a price of $9.15 per share.
• Following the transaction, Pickert directly owns 65,924 shares of common stock.
• Pickert also indirectly owns 7,150 shares through The Curtis B. Pickert Revocable Trust, of which he is the trustee and his immediate family members are beneficiaries.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing a routine stock transaction. It doesn't inherently convey positive or negative sentiment.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. These filings are closely watched by investors seeking insights into management's perspective on the company's stock.

Stakeholder Impact

• The transaction has a minimal direct impact on stakeholders, as it is a routine sale of shares by an executive to cover tax obligations.

Key Dates